NCT02905149

Brief Summary

The purpose of this project is to evaluate the analgesic efficacy of a regional anesthesia technique ( interfascial block at the serratus muscle) performed in patient undergoing breast surgery and the effect of this technique on postoperative analgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4 surgery

Timeline
Completed

Started Aug 2016

Shorter than P25 for phase_4 surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 14, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 19, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2017

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

March 2, 2020

Completed
Last Updated

March 2, 2020

Status Verified

August 1, 2017

Enrollment Period

10 months

First QC Date

September 14, 2016

Results QC Date

October 21, 2019

Last Update Submit

February 27, 2020

Conditions

Keywords

OncologicalSurgeryBreastReconstruction

Outcome Measures

Primary Outcomes (1)

  • Total Opioid Usage

    Total opioid usage in the first 24 hours (intra and postoperative) (in morphine milligrmas, fentanyl/morphine conversion = 10 mcgs/1mg). Opioid used will be fentanyl and morphine. Fentanyl will be converted in morphine milligrams equivlents to caluclate the total first 24H dose.

    First 24 hours after surgery

Secondary Outcomes (3)

  • Pain at Rest and Coughing

    First 24 hours after surgery

  • Time to First Opioid Administration on the Ward

    First 24 hours after surgery

  • Presence of Opioid Related Complications

    First 24 hours after surgery

Study Arms (2)

Serrato

EXPERIMENTAL

Standard anesthesia+serratus plane block.

Procedure: Serrato

Control

PLACEBO COMPARATOR

Standard anesthesia

Procedure: Control

Interventions

SerratoPROCEDURE

Serratus plane block.

Serrato
ControlPROCEDURE

Standard anesthesia

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years, undergoing oncological surgery and/or breast reconstruction surgery whose pathology and surgical intervention supose at least a 24 hours hospital admission

You may not qualify if:

  • ASA Physical Status Classification System- IV.- Morbid obesity (Body mass index \>40). -Impossibility of anatomical structures ultrasound identification in a satisfactory way (there can be no distinction in the interfascial plane between serratus and pectoral muscle). -Opioids treatment before surgery. Sepsis and/or infection at the puncture site.
  • Haemostasis disorders. - Allergy to any of the drugs used in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Manises

Manises, Valencia, 46940, Spain

Location

Related Publications (1)

  • Mazzinari G, Rovira L, Casasempere A, Ortega J, Cort L, Esparza-Minana JM, Belaouchi M. Interfascial block at the serratus muscle plane versus conventional analgesia in breast surgery: a randomized controlled trial. Reg Anesth Pain Med. 2019 Jan;44(1):52-58. doi: 10.1136/rapm-2018-000004.

Limitations and Caveats

The blinding method cannot entirely exclude ascertainment bias.

Results Point of Contact

Title
Maria Cortell
Organization
Instituto de Investigación Sanitaria La Fe

Study Officials

  • Guido Mazzinari

    Instituto de Investigación Sanitaria La Fe

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two group parallel arm. With study group receiving regional anesthestic block with levobupivacaine and control group receiving standard care with intravenous analgesia only
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2016

First Posted

September 19, 2016

Study Start

August 2, 2016

Primary Completion

June 8, 2017

Study Completion

July 8, 2017

Last Updated

March 2, 2020

Results First Posted

March 2, 2020

Record last verified: 2017-08

Locations